In the BioHarmony Drug Report Database

"Preview" Icon

Etoposide

Vepesid (etoposide) is a small molecule pharmaceutical. Etoposide was first approved as Vepesid on 1983-11-10. It is used to treat brain neoplasms, ewing sarcoma, histiocytosis, kaposi sarcoma, and lung neoplasms amongst others in the USA. The pharmaceutical is active against DNA topoisomerase 2-alpha. In addition, it is known to target DNA topoisomerase 2-beta.

 

Trade Name

 

Vepesid
 

Common Name

 

etoposide
 

ChEMBL ID

 

CHEMBL44657
 

Indication

 

brain neoplasms, ewing sarcoma, histiocytosis, kaposi sarcoma, lung neoplasms, mycosis fungoides, myeloid leukemia acute, neuroblastoma, prostatic neoplasms, rhabdomyosarcoma, testicular neoplasms, trophoblastic neoplasms, urinary bladder neoplasms, uterine neoplasms
 

Drug Class

 

Image (chem structure or protein)

Etoposide structure rendering